Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision (Q40555875)

21 September 2017

title

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision (English)

1 reference

21 September 2017

Liu GT

1

1 reference

21 September 2017

Glaser JS

series ordinal

2

1 reference

21 September 2017

Schatz NJ

series ordinal

3

1 reference

21 September 2017

Smith JL

series ordinal

4

1 reference

21 September 2017

publication date

1 November 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

101

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

1779-1785

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

21 September 2017

1 reference

7 January 2021

Visual prognosis in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Temporal arteritis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Occult temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Occult temporal arteritis. A common cause of blindness in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Temporal arteritis. A 14-year epidemiological, clinical and prognostic study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Formed visual hallucinations: a symptom of cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Ophthalmoplegia in cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Anterior Ischemic Optic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

IV steroid treatment of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Fluorescein angiography in the diagnosis of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Neurologic aspects of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

The ocular crisis of the temporal arteritis syndrome (Horton)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Ischaemic optic neuropathy. The clinical profile and history

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Clinical profile and long-term implications of anterior ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Controversies regarding Giant cell (Temporal, Cranial) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Treatment of temporal arteritis with ocular involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Reversal of blindness in temporal arteritis with methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Treatable blindness in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Visual Recovery in Two Patients after Intravenous Methylprednisolone Treatment of Central Retinal Artery Occlusion Secondary to Giant-cell Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

IV steroids for central retinal artery occlusion in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Prevention of blindness in giant cell arteritis by corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Temporal arteritis. Occurrence of ocular complications 7 years after diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

Progressive Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis Despite High-Dose Intravenous Corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2894%2931102-X

7 January 2021

10.1016/S0161-6420(94)31102-X

Identifiers

DOI

1 reference

21 September 2017

1 reference